Wavelength Pharma Names Former Sun Exec as New CEO Post author:Sam Post published:November 28, 2017 Post category:BioPharma Iftach Seri previously served as Sun Pharmaceutical’s head of API. Source: BioSpace You Might Also Like FDA Grants Priority Review for Prostrate Cancer Treatment March 19, 2018 Achillion Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor August 8, 2017 This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG May 7, 2017
Achillion Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor August 8, 2017
